Cigna Group stock was falling sharply after the health insurer missed quarterly earnings estimates and issued light guidance ...

Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as ...

Cigna (CI) stock falls as the managed care company's Q4 2024 earnings miss the consensus due to an unexpected rise in medical costs. Read more here.

Cigna Group shares fell sharply after the health insurer reported fourth-quarter profit that was dragged down by medical costs, a trend that’s concerned investors in the sector for months.

Cigna said its medical loss ratio was 87.9% in Q4 2024, compared to 82.2% in the prior-year quarter. For the full-year 2024, MLR was 83.2%, which was still higher compared to the 81.3% its insurance ...

Reports Q4 revenue $65.65B, consensus $63.18B. “While higher medical costs in our stop loss product impacted fourth quarter earnings, we are ...

Cigna reported fourth-quarter revenue of $65.68 billion, beating analyst estimates of $63.36 billion, according to Benzinga Pro. The company reported fourth-quarter adjusted earnings of $6.64 per ...

Cigna Healthcare customer service is available 24 hours a day, 365 days a year at 800-244-6224. Members may also find in-network providers through myCigna® or the myCigna® app.

Global health insurance company The Cigna Group CI is set to report fourth-quarter 2024 results on Jan. 30, 2025, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s ...

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

TD Cowen analyst Ryan Langston maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $391.00. The company’s ...

Group plunged 10.6% in premarket trading on Thursday after the health insurer reported fourth-quarter earnings that fell short of analyst expectations and provided a weaker-than-anticipated outlook ...